SEC Form 4 · accession 0001562180-18-000321
Intersect ENT, Inc. · XENT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gwen R. Carscadden
Officer — Chief People Officer
Period of report
Jan 12, 2018
Accepted (ET)
Jan 16, 2018 · 5:57 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001271214
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 12, 2018 | M | 10,000 | $12.19 | A | 13,856 | D | |
| Common StockF2 | Jan 12, 2018 | S | 10,000 | $34.3476 | D | 3,856 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to buy)F3 | $12.19 | Jan 12, 2018 | M | 10,000 | D | — | Jun 27, 2026 | Common Stock | 10,000 | 40,000 | D |
Explanation of responses
- F1The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2017.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.15 to $34.55. inclusive. The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote on this Form 4.
- F3The shares subject to the option vest commencing June 27, 2016. 25% of the shares subject to the option vested on June 27, 2017 and 1/48th of the shares subject to the option vests monthly thereafter over three (3) years.